Roche focuses on areas of unmet medical needs – and where we have the expertise to make a difference in improving people’s lives.
From our early days as a developer of neuropsychology, speciality antibiotics and anti-inflammatory drugs, Roche has a history of transcending conventional boundaries to deliver therapies that improve and save the lives of our customers. Our innovative approach increases the effectiveness and efficiency of the healthcare system in the diagnosis, treatment and management of acute and long-term diseases.
Roche products hold a prominent position in many major therapeutic areas, including oncology (cancer), virology, transplantation, and inflammatory and autoimmune disease. While Roche will continue to hold a strong position as a specialist healthcare provider, it is also playing an important role in the primary care arena, through medicines to treat diseases such as influenza, as well as a strong development pipeline in areas such as metabolic disorder.
The Roche Group is focused on holding its place on the world pharmaceutical stage as a leading research and development company in all areas of its business. We are committed to taking advantage of new technologies and discoveries to deliver superior quality medicines to our customers.